Articles

O.05 Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial

BJMO - 2017, issue 3, february 2017

L. Buisseret MD, S. Pommey , B. Allard , S. Garaud , M-A. Bergeron , I. Cousineau , L. Ameye , G. Chouinard , H. Duvillier , M. Paesmans , M.J. Piccart-Gebhart MD, K. Willard-Gallo , C. Sotiriou MD, PhD, J. Stagg

Read more